Ascendis Pharma A/S ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.87 |
Market Cap |
$5.27 B |
Shares Outstanding |
46.3 M |
Public Float |
38.01 M |
Address |
Tuborg Boulevard 12 Hellerup CR 2900 Denmark |
Employees | - |
Website | http://www.ascendispharma.com |
Updated | 07/08/2019 |
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark. |